Antimicrobial polymer layers
The invention provides compositions comprising a plurality of polymer layers for preventing or inhibiting microbial infections. Specifically, the invention provides a combination of a cationic polymer layer that resists adhesion of a microbe to its surface and an anionic polymer layer that releases a cationic anti-microbial agent in response to a change in pH or electrostatic balance.
1. An article comprising a substrate comprising a surface, wherein the surface of the substrate comprises:
a first polymer layer comprising an anionic polymer,
a second polymer layer exposed to a biological tissue or a biological system comprising a cationic polymer,
wherein said cationic polymer comprises a chitosan modified with 25% to 50% quaternary ammonium salts, a chitosan modified with about 40% carboxylic acid, or a combination thereof,
wherein said first polymer layer is an end-grafted polymer brush immobilized on the surface of said substrate, and
wherein said second polymer layer overlays, directly contacts, and is covalently cross-linked to said first polymer layer,
and an anti-microbial agent sequestered in said first polymer layer,
wherein said agent is sequestered at a physiological pH, and wherein said polymers are configured to release said agent at an acidic pH.
2. The article of claim 1 , wherein said physiological pH ranges from about 7.35 to about 7.45.
3. The article of claim 1 , wherein acidic pH ranges from about 2.0 to about 6.9.
4. The article of claim 1 , wherein said acidic pH is caused by or associated with bacterial infection from a biofilm.
5. The article of claim 1 , wherein said second layer resists adhesion of a microbe to its surface.
6. The article of claim 5 , wherein said microbe is a bacterium.
7. The article of claim 6 , wherein said bacteria is Staphylococcus aureus or Pseudomonas aeruginosa.
8. The article of claim 1 , wherein said agent comprises a cation.
9. The article of claim 1 , wherein said anionic polymer is poly(acrylic acid) (PAA), alginic acid (ALG), poly (aspartic acid), poly (glutamic acid) (PGA), hyaluronic acid, or poly(styrenesulfonate).
10. The article of claim 1 , wherein said agent comprises an amine group.
11. The article of claim 1 , wherein said agent is an antibiotic.
12. The article of claim 11 , wherein said agent is an aminoglycoside.
13. The article of claim 1 , wherein said substrate is a medical material, device, or implant.
14. The article of claim 13 , wherein said substrate is selected from a catheter, bandage, adhesive, gauze strip, gauze pad, medical or surgical drape, syringe holder, suture, IV tubing, IV bag, stent, guide wire, prosthesis, orthopedic pin, dental material, pacemaker, heart valve, artificial heart, knee and hip joint implant, bone cement, vascular graft, urinary catheter, ostomy port, orthopedic fixture, pacemaker lead, defibrillator lead, ear canal shunt, cosmetic implant, ENT (ear, nose, throat) implant, staple, implantable pump, hernia patch, plate, screw, blood bag, external blood pump, fluid administration system, ventilator, endotracheal tube, heart-lung machine, dialysis equipment, artificial skin, ventricular assist device, hearing aid, or dental implant.
15. The article of claim 1 , wherein the surface of said substrate is glass, plastic, metal, or polymer.
16. An anti-microbial material comprising a plurality of polymer layers and an anti-microbial agent sequestered therein, said plurality of polymer layers comprise
a first polymer comprising an anionic polymer and
a second polymer layer exposed to a biological tissue or a biological system comprising a cationic polymer overlaying and directly contacting said first polymer layer,
wherein said cationic polymer comprises a chitosan modified with about 25% to about 50% quaternary ammonium salts, a chitosan modified with about 40% carboxylic acid, or a combination thereof,
wherein said first polymer layer is an end-grafted polymer brush immobilized on the surface of a substrate, and
wherein said second polymer layer overlays and is covalently cross-linked to said first polymer layer,
wherein said agent remains sequestered at a physiological pH, and
wherein said polymers are configured to release said agent at an acidic pH.
17. The material of claim 16 , wherein said anionic polymer is poly(acrylic acid) (PAA), alginic acid (ALG), poly (aspartic acid), poly (glutamic acid) (PGA), hyaluronic acid, or poly(styrenesulfonate).
18. The material of claim 16 , wherein said anti-microbial agent is an antibiotic.
19. The material of claim 18 , wherein said antibiotic is an aminoglycoside.
20. A method for providing an anti-microbial coating on a surface of an article, the method comprising:
immobilizing an anionic polymer on the surface of said article by end-grafting said anionic polymer to form a first polymer brush layer;
coating and covalently cross-linking a cationic polymer directly on the first polymer brush layer to form a second polymer layer exposed to a biological tissue or a biological system, wherein said cationic polymer comprises a chitosan modified with 25% to 50% quaternary ammonium salts, a chitosan modified with about 40% carboxylic acid, or a combination thereof; and
sequestering an anti-microbial agent in said anionic polymer, wherein said agent is sequestered at a physiological pH, and wherein said polymers are configured to release said agent at an acidic pH.
21. The method of claim 20 , wherein the step of sequestering said anti-microbial agent comprises the steps of loading the first polymer layer with the anti-microbial agent by exposing the first polymer layer to an acidic pH in the presence of the anti-microbial agent; and raising the pH to a physiological pH.
22. The method of claim 20 , wherein the sequestering step is performed prior to the coating of the cationic polymer on the first polymer layer.
23. The method of claim 20 , further comprising the step of drying the anti-microbial coating on the surface of the article.
24. The method of claim 20 , wherein said anionic polymer layer is poly(acrylic acid) (PAA), alginic acid (ALG), poly (aspartic acid), poly (glutamic acid) (PGA), hyaluronic acid, or poly(styrenesulfonate).
25. The method of claim 20 , wherein said agent is an antibiotic.
26. The method of claim 25 , wherein said antibiotic is an aminoglycoside.
27. The method of claim 20 , wherein said article is a medical material, device or implant.
28. The method of claim 20 , wherein the surface of the article is glass, plastic, metal, or polymer.
29. A method for inhibiting a microbial infection associated with the use of a medical material, device, or implant, the method comprising: providing a medical material, device, or implant having a surface coated with the anti-microbial material of claim 16 ; contacting the coated medical material, device, or implant with a potential source of the microbial infection.
30. An article comprising a substrate comprising a surface, wherein the surface of the substrate comprises:
a first polymer layer comprising an anionic polymer selected from the group consisting of poly(acrylic acid) (PAA), alginic acid (ALG), poly (aspartic acid), poly (glutamic acid) (PGA), hyaluronic acid, or poly(styrenesulfonate),
a second polymer layer exposed to a biological tissue or a biological system comprising a cationic polymer selected from the group consisting of a chitosan modified with 25% to 50% quaternary ammonium salts and a chitosan modified with about 40% carboxylic acid,
wherein said first polymer layer is an end-grafted polymer brush immobilized on the surface of said substrate, and
wherein said second polymer layer overlays directly contacts, and is covalently cross-linked to said first polymer layer,
and an anti-microbial pathogen agent sequestered in said first polymer layer,
wherein said agent is sequestered at a physiological pH, and
wherein said polymers are configured to release said agent at an acidic pH.